Atlas Trials

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects

Clinical trial NCT02479022 · COMPLETED

Trial details

NCT number
NCT02479022
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2Healthy
Start date
2015-06-01
Primary completion
2015-12-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.